Immunovia AB (publ) (STO:IMMNOV)

Immunovia AB Revenue

Immunovia AB had revenue of 201.00K SEK in the quarter ending March 31, 2025, with 28.85% growth. This brings the company's revenue in the last twelve months to 528.00K, down -68.17% year-over-year. In the year 2024, Immunovia AB had annual revenue of 931.00K, down -40.89%.

• Revenue (ttm): 528.00K
• Revenue Growth: -68.17%
• P/S Ratio: 200.58
• Revenue / Employee: 58.67K
• Employees: 9
• Market Cap: 105.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	931.00K	-644.00K	-40.89%
Dec 31, 2023	1.58M	430.00K	37.55%
Dec 31, 2022	1.15M	301.00K	35.66%
Dec 31, 2021	844.00K	482.00K	133.15%
Dec 31, 2020	362.00K	6.00K	1.69%